These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The ocular hypotensive effect of the ETB receptor selective agonist, sarafotoxin S6c, in rabbits. Haque MS; Taniguchi T; Sugiyama K; Okada K; Kitazawa Y Invest Ophthalmol Vis Sci; 1995 Apr; 36(5):804-8. PubMed ID: 7706028 [TBL] [Abstract][Full Text] [Related]
3. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle. Yousufzai SY; Ali N; Abdel-Latif AA Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3245-53. PubMed ID: 10586949 [TBL] [Abstract][Full Text] [Related]
4. The effects of endothelin-1 on intraocular pressure and pupillary diameter in rabbits. Okada K; Sugiyama K; Haque MS; Taniguchi T; Kitazawa Y Jpn J Ophthalmol; 1995; 39(3):233-41. PubMed ID: 8577073 [TBL] [Abstract][Full Text] [Related]
5. Effects of calcitonin gene-related peptide in the eye. A study in rabbits and cats. Oksala O; Stjernschantz J Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1006-11. PubMed ID: 3262093 [TBL] [Abstract][Full Text] [Related]
6. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats. Lemaitre C; Thillaye-Goldenberg B; Naud MC; de Kozak Y Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2022-30. PubMed ID: 11481267 [TBL] [Abstract][Full Text] [Related]
7. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Russell KR; Wang DR; Potter DE Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526 [TBL] [Abstract][Full Text] [Related]
8. The effect of intravitreal and topical prostaglandins on intraocular inflammation. Kulkarni PS; Srinivasan BD Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005 [TBL] [Abstract][Full Text] [Related]
9. The effects of ETB receptor-selective agonist on IOP and blood-aqueous barrier in rabbit eyes: role of cyclooxygenase products. Haque MS; Sugiyama K; Taniguchi T; Okada K; Nakai Y; Kitazawa Y Jpn J Ophthalmol; 1995; 39(4):360-7. PubMed ID: 8926643 [TBL] [Abstract][Full Text] [Related]
10. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit. Takashima Y; Taniguchi T; Yoshida M; Haque MS; Yoshimura N; Honda Y Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2671-7. PubMed ID: 8977481 [TBL] [Abstract][Full Text] [Related]
12. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist. Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608 [TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells. Schwarz N; Renshaw D; Kapas S; Hinson JP J Endocrinol; 2006 Aug; 190(2):505-14. PubMed ID: 16899583 [TBL] [Abstract][Full Text] [Related]
14. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. Ogidigben M; Chu TC; Potter DE J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435 [TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates. Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717 [TBL] [Abstract][Full Text] [Related]
16. Ocular hypotensive and vasodilative effects of two beta-adrenergic blockers with intrinsic sympathomimetic activity. Hong SJ; Wu KY; Chen IJ Curr Eye Res; 1998 Jul; 17(7):700-7. PubMed ID: 9678415 [TBL] [Abstract][Full Text] [Related]
17. Ocular actions of moxonidine: a possible role for imidazoline receptors. Ogidigben M; Chu TC; Potter DE J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282 [TBL] [Abstract][Full Text] [Related]
18. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin. Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718 [TBL] [Abstract][Full Text] [Related]
19. Aqueous humor messengers in the transient decrease of intraocular pressure after ganglionectomy. Liu JH Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3181-5. PubMed ID: 1328112 [TBL] [Abstract][Full Text] [Related]
20. Apraclonidine effects on ocular responses to YAG laser irradiation to the rabbit iris. Sugiyama K; Kitazawa Y; Kawai K Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):708-14. PubMed ID: 2186009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]